Physician profile
Mary E Shellhouse
NPI 1639143837
$381.52
in general payments reported to CMS, 2019-2025
12 companies · $24.96 in 2025
The $24.96 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $78.61 · 2023: $33.78 · 2024: $13.57 · 2025: $24.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $125.00 | 2021 | |
| Amgen INC. | $43.05 | 2021-2022 | |
| Abbvie INC. | $35.11 | 2021-2024 | |
| Astellas Pharma US INC | $33.78 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $32.95 | 2021-2022 | |
| Sage Therapeutics, LLC | $24.96 | 2025 | Zurzuvae |
| Organon LLC | $18.55 | 2022 | |
| Daiichi Sankyo INC. | $17.76 | 2021 | |
| Avion Pharmaceuticals | $14.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.37 | 2022 | |
| Therapeuticsmd, INC. | $11.84 | 2021 | |
| Lilly USA, LLC | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Shellhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.